Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Anglo-Saxon eye remedy kills MRSA
Bald's Leechbook
Scientists recreated a 10th century potion for eye infections from Bald's Leechbook, an old medical textbook.
Researchers 'genuinely astonished'

An Anglo-Saxon remedy for eye infections could be the answer to killing the antibiotic superbug MRSA, according to research led by the University of Nottingham.

Scientists recreated a 10th century potion for eye infections from Bald's Leechbook, an old medical textbook in the British Library, to see if it really works as a remedy.

They were astonished to find that the 'potion', made of garlic, onion and parts of a cow's stomach, has remarkable effects on Methicillen-resistant Staphylococcus aureus (MRSA).

The team now has data showing that Bald's eye treatment kills up to 90 per cent of MRSA bacteria in 'in vivo' wound biopsies from mouse models.  

Anglo-Saxon expert Dr Christina Lee from the University of Nottingham translated the recipe for the eye salve, which contained garlic, onion, wine and oxgall (bile from a cow's stomach).

Experts from the University's microbiology team then duplicated the remedy and tested it on MRSA cultures both in synthetic wounds and in infected wounds in mice.  

Commenting on the study, Dr Lee said: “We were genuinely astonished at the results of our experiments in the lab. We believe modern research into disease can benefit from past responses and knowledge, which is largely contained in non-scientific writings. But the potential of these texts to contribute to addressing the challenges cannot be understood without the combined expertise of both the arts and science."

Microbiologist, Dr Freya Harrison added: “We thought that Bald’s eye salve might show a small amount of antibiotic activity, because each of the ingredients has been shown by other researchers to have some effect on bacteria in the lab – copper and bile salts can kill bacteria, and the garlic family of plants make chemicals that interfere with the bacteria’s ability to damage infected tissues.

"But we were absolutely blown away by just how effective the combination of ingredients was. We tested it in difficult conditions too; we let our artificial ‘infections’ grow into dense, mature populations called ‘biofilms’, where the individual cells bunch together and make a sticky coating that makes it hard for antibiotics to reach them. But unlike many modern antibiotics, Bald’s eye salve has the power to breach these defences.”

The team are due to present their findings at the Annual Conference for the Society for General Microbiology. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.